Korea News
-
Graft versus host disease market to grow at 8.2% CAGR across 5 APAC markets in 10 years
Korea | News | 0 Comment | 27 Aug, 2020
The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...Read more
-
Celltrion initiates Ph I trial for COVID-19 drug in Korea
Korea | News | 0 Comment | 27 Aug, 2020
Celltrion Group has announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved the company’s I...Read more
-
Seoul Viosys promotes violeds to sterilize coronavirus
Korea | News | 0 Comment | 24 Aug, 2020
South Korea based Seoul Viosys, is promoting new Violeds technology solution, the world’s first ultraviolet LED te...Read more
-
KT Corp develops AI-based COVID-19 research
Korea | News | 0 Comment | 21 Aug, 2020
KT Corp., South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment...Read more
-
South Korean church donates plasma worth $83B for COVID-19 cure
Korea | News | 1 Comment | 20 Aug, 2020
At a time when the entire world is reeling under the impact of COVID-19, members of Shincheonji Church from South Korea ...Read more
-
LG Chem & TransThera Bio to work on chronic inflammatory conditions
Korea | News | 0 Comment | 18 Aug, 2020
South Korean firm LG Chem Life Sciences, a division of LG Chem, and TransThera Biosciences Co. Ltd., a clinical-stage bi...Read more
-
Novavax, SK Bioscience announce COVID-19 vaccine collaboration
Korea | News | 0 Comment | 17 Aug, 2020
US based Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious di...Read more
-
Samsung Biologics invests $2B for further expansion
Korea | News | 0 Comment | 13 Aug, 2020
South Korea based Samsung Biologics held an online press conference to announce its plans to break ground for a ...Read more
-
Celltrion to launch antigen and antibody testing kits in US
Korea | News | 0 Comment | 14 Aug, 2020
South Korea based Celltrion Group recently announced the launch of two rapid kits for SARS-CoV-2 in the US by the third ...Read more
-
Mankind, Daewoong Pharma to use Niclosamide for COVID-19 treatment
Korea | News | 0 Comment | 11 Aug, 2020
Daewoong Pharmaceutical Co. Ltd., South Korea (through its subsidiary, Daewoong Pharmaceutical India Pvt. Ltd.) and Mank...Read more
-
Merck & Hanmi to develop, commercialise therapy for NASH
Korea | News | 0 Comment | 12 Aug, 2020
Merck, and Hanmi Pharmaceutical (Korea-based pharmaceutical company) have announced that the companies have entered in...Read more
-
Samsung Biologics launches S-CHOice cell line expression technology
Korea | News | 0 Comment | 06 Aug, 2020
South Korean firm Samsung Biologics held an online ceremony to announce the launch of its proprietary cell line technolo...Read more
-
Macrogen obtains CE-IVD mark for COVID-19 test kit
Korea | News | 0 Comment | 04 Aug, 2020
Korean biotech company Macrogen has recently announced that it has obtained the CE marking for Europe's I...Read more
-
PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC
Korea | News | 0 Comment | 05 Aug, 2020
South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...Read more
-
GC Pharma Files IND for Hyperimmune Globulin-based Therapy for COVID-19
Korea | News | 0 Comment | 03 Aug, 2020
Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...Read more
-
Seegene receives expanded EUA for COVID-19 diagnostic assay
Korea | News | 0 Comment | 31 Jul, 2020
South Korean firm Seegene, Inc. has announced that U.S. Food and Drug Administration (FDA) has further expanded the emer...Read more
-
Samsung Biologics expands drug product manufacturing facility in Incheon
Korea | News | 0 Comment | 24 Jul, 2020
South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...Read more
-
Celltrion launches human trial of potential COVID-19 Ab treatment
Korea | News | 0 Comment | 23 Jul, 2020
South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...Read more
